Earningsreport

Q1/2023 3/31/2023 EPS -0.290 ZacksConsensus -0.290 ActVsEst 0.000 - In-Line

CollPlant Biotechnologies Ltd. - Ordinary Shares  (CLGN) 
US:NASDAQ Investor Relations: collplant.com/investor-relation